Natural supplement combo may match standard drug for prostate relief
NCT ID NCT07665749
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will compare two treatments for moderate to severe urinary symptoms caused by an enlarged prostate. One group takes a standard drug (alfalitic) plus a natural supplement (Serenoa repens, or saw palmetto), while the other takes the same drug plus another standard medication (antimuscarinic). The goal is to see if the natural supplement combo works just as well, with fewer side effects. Fifty men aged 40 to 80 will be followed for 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
alfalitic plus Serenoa repens (saw palmetto extract)
What this could lead to
If successful, this could show that a combination with a natural supplement works as well as one with a standard drug, potentially offering a gentler option for managing urinary symptoms.
What could go wrong
This is a small, early-stage study with only 50 participants. It compares existing treatments, not a new breakthrough, so results may not change standard care. Side effects are still possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATE HYPERTROPHY(BPH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••